Brainomix
Medical Equipment ManufacturingEngland, United Kingdom51-200 Employees
Brainomix develops AI-powered imaging solutions for medical centers, turning routine scans into actionable insights to support decisions in stroke and lung care. Its Brainomix 360 platform is designed to improve interpretation of stroke imaging for neurologists, interventionalists, and radiologists while integrating with existing radiology workflows. The company began as a spin-out from the University of Oxford in 2010 and has built a portfolio of imaging biomarkers and software tools used by physicians worldwide. Headquartered in Oxford, England, Brainomix operates in the medical equipment sector with a focus on AI-enabled imaging. Its customers are healthcare providers involved in acute stroke care, and its solutions support critical decision-making along the stroke pathway. In March 2026, Brainomix launched Brainomix 360 Stroke and announced deployment across the West Virginia University Health System network.